NCT01080144

Brief Summary

All patients eligible for TIPS (Transjugular intrahepatic portosystemic shunt) procedure will be considered for inclusion. After written inform consent, psychometric tests in order to calculate the psychometric hepatic encephalopathy (PHES) score, the gold standard for the diagnosis of minimal encephalopathy and critical flicker frequency (CFF) will be performed before the TIPS procedure. After TIPS, patients will be followed during one year and the psychometric test and CFF will be performed every 3 months. 30 patients will be included. The main endpoint is the success rate of CFF. The secondary end points are

  • Correlation between CFF and PHES score
  • Performance of CFF and PHES score to predict the occurrence of overt encephalopathy after TIPS procedure
  • A sample collection during TIPS procedure is also performed for validation of biomarkers

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 3, 2010

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

May 11, 2017

Status Verified

May 1, 2017

Enrollment Period

3 years

First QC Date

March 2, 2010

Last Update Submit

May 10, 2017

Conditions

Keywords

CirrhosisTIPS (Transjugular intrahepatic portosystemic shunt)Encephalopathy

Outcome Measures

Primary Outcomes (1)

  • success rate of Critical Flicker Frequency (CFF) Procedure

    number of patients in whom ten measurement will be available / 30 patients

    before TIPS and every 3 months till one year

Secondary Outcomes (1)

  • occurrence of encephalopathy

    every 3 months till one year after TIPS procedure

Study Arms (1)

Critical Flicker Frequency

EXPERIMENTAL

Critical Flicker Frequency Procedure

Other: Critical flicker frequency procedure

Interventions

After TIPS, patients will be followed during one year and the psychometric test and Critical flicker frequency procedure will be performed every 3 months

Critical Flicker Frequency

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with cirrhosis in whom a TIPS is indicated
  • patients have given their informed consent te be included

You may not qualify if:

  • minor
  • pregnant women
  • patients who cannot see the red color
  • refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Christophe Bureau

Toulouse, Hôpital Rangueil, 31000, France

Location

Related Publications (1)

  • Berlioux P, Robic MA, Poirson H, Metivier S, Otal P, Barret C, Lopez F, Peron JM, Vinel JP, Bureau C. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatology. 2014 Feb;59(2):622-9. doi: 10.1002/hep.26684.

MeSH Terms

Conditions

FibrosisBrain Diseases

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Christophe Bureau, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2010

First Posted

March 3, 2010

Study Start

October 1, 2009

Primary Completion

October 1, 2012

Study Completion

December 1, 2012

Last Updated

May 11, 2017

Record last verified: 2017-05

Locations